Development of a set of quality indicators in paediatric and perinatal care in Japan with a modified Delphi method.
Epidemiology
Health services research
Information Technology
Journal
BMJ paediatrics open
ISSN: 2399-9772
Titre abrégé: BMJ Paediatr Open
Pays: England
ID NLM: 101715309
Informations de publication
Date de publication:
11 2023
11 2023
Historique:
received:
28
07
2023
accepted:
30
10
2023
medline:
10
11
2023
pubmed:
9
11
2023
entrez:
8
11
2023
Statut:
ppublish
Résumé
Few paediatric and perinatal quality indicators (QIs) have been developed in the Japanese setting, and the quality of care is not assured or validated. The aim of this study was to develop QIs in paediatric and perinatal care in Japan using an administrative database and confirm the feasibility and applicability of the indicators using a single-site practice test. We used a RAND-modified Delphi method that integrates evidence review with expert consensus development. QI candidates were generated from clinical practice guidelines (CPGs) available in English or Japanese and existing QIs in nine selected paediatric or perinatal conditions. Consensus building was based on independent panel ratings. The performance of QIs was retrospectively assessed using data from an administrative database at the National Children's Hospital. Data between April 2018 and March 2019 were used, while data between April 2019 and March 2021 were also used for selected condition, considering the small number of patients. Each QI was calculated as follows: number of times the indicator was met/number of participants×100. From the literature review conducted between 2010 and 2020, 124 CPGs and 193 existing indicators were identified to generate QI candidates. Through the consensus-building process, 133 QI candidates were assessed and 79 QIs were accepted. The practice test revealed wide variations in the process-level performance of QIs in four categories: patient safety: median 43.9% (IQR 16.7%-85.6%), general paediatrics: median 98.8% (IQR 84.2%-100%), advanced paediatrics: median 94.4% (IQR 46.0%-100%) and advanced obstetrics: median 80.3% (IQR 59.6%-100%). We established 79 QIs for paediatric and perinatal care in Japan using an administrative database that can be applied to hospitals nationwide. The practice test confirmed the measurability of the developed QIs. Benchmarking these QIs will be an attractive approach to improving the quality of care.
Sections du résumé
BACKGROUNDS
Few paediatric and perinatal quality indicators (QIs) have been developed in the Japanese setting, and the quality of care is not assured or validated. The aim of this study was to develop QIs in paediatric and perinatal care in Japan using an administrative database and confirm the feasibility and applicability of the indicators using a single-site practice test.
METHODS
We used a RAND-modified Delphi method that integrates evidence review with expert consensus development. QI candidates were generated from clinical practice guidelines (CPGs) available in English or Japanese and existing QIs in nine selected paediatric or perinatal conditions. Consensus building was based on independent panel ratings. The performance of QIs was retrospectively assessed using data from an administrative database at the National Children's Hospital. Data between April 2018 and March 2019 were used, while data between April 2019 and March 2021 were also used for selected condition, considering the small number of patients. Each QI was calculated as follows: number of times the indicator was met/number of participants×100.
RESULTS
From the literature review conducted between 2010 and 2020, 124 CPGs and 193 existing indicators were identified to generate QI candidates. Through the consensus-building process, 133 QI candidates were assessed and 79 QIs were accepted. The practice test revealed wide variations in the process-level performance of QIs in four categories: patient safety: median 43.9% (IQR 16.7%-85.6%), general paediatrics: median 98.8% (IQR 84.2%-100%), advanced paediatrics: median 94.4% (IQR 46.0%-100%) and advanced obstetrics: median 80.3% (IQR 59.6%-100%).
CONCLUSIONS
We established 79 QIs for paediatric and perinatal care in Japan using an administrative database that can be applied to hospitals nationwide. The practice test confirmed the measurability of the developed QIs. Benchmarking these QIs will be an attractive approach to improving the quality of care.
Identifiants
pubmed: 37940343
pii: 10.1136/bmjpo-2023-002209
doi: 10.1136/bmjpo-2023-002209
pmc: PMC10632888
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared
Références
Health Aff (Millwood). 2017 Jul 1;36(7):1234-1243
pubmed: 28679810
Eur J Cancer. 2019 Mar;109:111-119
pubmed: 30716714
Eur J Public Health. 2015 Oct;25(5):787-91
pubmed: 25983328
BMC Health Serv Res. 2013 Jan 27;13:31
pubmed: 23351430
BJOG. 2018 Jun;125(7):857-865
pubmed: 29105913
Seizure. 2019 Apr;67:52-56
pubmed: 30903922
J Pediatr Gastroenterol Nutr. 2019 Jan;68(1):13-16
pubmed: 30074577
Eur J Pediatr. 2019 May;178(5):707-719
pubmed: 30798371
Med Care. 2009 Jul;47(7 Suppl 1):S51-5
pubmed: 19536019
J Epidemiol. 2021 Jan 5;31(1):1-11
pubmed: 33012777
BMC Pregnancy Childbirth. 2017 Sep 22;17(1):315
pubmed: 28938879
JAMA. 2022 Mar 1;327(9):815-816
pubmed: 35085389
Int Arch Allergy Immunol. 2020;181(12):926-933
pubmed: 33091910
Hum Reprod. 2013 Apr;28(4):987-96
pubmed: 23411619
BMJ Qual Saf. 2016 Jul;25(7):525-34
pubmed: 26384710
BMJ. 2003 Apr 12;326(7393):816-9
pubmed: 12689983
Int J Radiat Oncol Biol Phys. 2013 Mar 15;85(4):904-11
pubmed: 23040217
PLoS One. 2019 Feb 12;14(2):e0211955
pubmed: 30753232
J Am Coll Cardiol. 2005 Apr 5;45(7):1147-56
pubmed: 15808779
BMC Health Serv Res. 2018 Sep 27;18(1):743
pubmed: 30261865
Circ J. 2019 Oct 25;83(11):2292-2302
pubmed: 31554766
Pharmacoepidemiol Drug Saf. 2023 Jul;32(7):705-717
pubmed: 37146098
JAMA Pediatr. 2022 Dec 1;176(12):1217-1224
pubmed: 36251290
J Am Heart Assoc. 2016 May 20;5(5):
pubmed: 27207997
Palliat Med. 2006 Dec;20(8):769-77
pubmed: 17148531
Int J Health Care Qual Assur. 2012;25(8):712-29
pubmed: 23276064
Pediatrics. 2013 Oct;132(4):752-62
pubmed: 24062374
J Clin Epidemiol. 2011 Aug;64(8):821-9
pubmed: 21194889
Implement Sci. 2012 Mar 21;7:21
pubmed: 22436067
Eur J Pediatr. 2018 Jun;177(6):921-933
pubmed: 29654400
Int J Qual Health Care. 2014 Apr;26 Suppl 1:108-15
pubmed: 24554645
Allergol Immunopathol (Madr). 2015 Mar-Apr;43(2):147-56
pubmed: 24731769
JAMA. 2018 Mar 20;319(11):1113-1124
pubmed: 29558552
Pediatrics. 2008 Jun;121(6):e1723-31
pubmed: 18474532
Crit Care Med. 2011 Apr;39(4):846-59
pubmed: 21317653